PB1930: EPIC: A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH FIRST-LINE ACALABRUTINIB THROUGH THE UK EARLY ACCESS PROGRAMME. INTERIM ANALYSIS UP TO 24 MONTHS

• Toby Eyre,
• Nicolas Martinez-Calle,
• Renata Walewska,
• Joe Hickey,
• Betina Blak,
• Anna Pickin,
• Sukhjit Hunjan,
• Orlaith Condon,
• Satoshi Hori

Affiliations

Toby Eyre

1 Oxford University Hospitals NHS Foundation Trust, Department of Clinical Haematology, Oxford, United Kingdom

Nicolas Martinez-Calle

2 Nottingham University Hospitals NHS Trust, Clinical Haematology, Nottingham, United Kingdom

Renata Walewska

3 University Hospitals Dorset NHS Foundation Trust, Bournemouth, United Kingdom

Joe Hickey

4 OPEN Health, Marlow, United Kingdom

Betina Blak

5 Astrazeneca, London, United Kingdom

Anna Pickin

5 Astrazeneca, London, United Kingdom

Sukhjit Hunjan

5 Astrazeneca, London, United Kingdom

Orlaith Condon

5 Astrazeneca, London, United Kingdom

Satoshi Hori

5 Astrazeneca, London, United Kingdom